Good practices for 89 Zr radiopharmaceutical production and quality control.
Thomas Erik WuenscheSerge LyashchenkoGuus A M S van DongenDanielle VugtsPublished in: EJNMMI radiopharmacy and chemistry (2024)
Zr-immuno-PET, new developments in chelator conjugation and radiolabeling procedures, application in novel compound classes, and improved PET scanner technology and quantification methods continue to reshape its landscape towards improving clinical outcomes.